Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis

Clinical trial NCT04607837 · COMPLETED

Trial details

NCT number: NCT04607837
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2021-04-12
Primary completion: 2024-06-19
Enrollment: 234

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.